Evotec has an interesting timeline / history:
https://www.evotec.com/en/about/history
from the ann:
"Evotec CEO, Dr Werner Lanthaler, commented, “we are very pleased to partner with Kazia for this promising asset, for which we have high hopes. Our corporate strategy does not provide for Evotec to take EVT801 through clinical trials itself, so we have sought to identify a partner who can do justice to the drug’s potential. We recognise Kazia’s track record and look forward to working together to make EVT801 available to patients and clinicians.”"
- Forums
- ASX - By Stock
- Ann: Kazia licenses EVT801 from Evotec
Evotec has an interesting timeline /...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)